期刊文献+

大鼠在体肠回流法研究环孢素纳米脂质体的吸收行为 被引量:6

Absorption behavior of cyclosporin nanoliposome by in situ circulation method in rats
下载PDF
导出
摘要 目的 :研究环孢素纳米脂质体在大鼠小肠的吸收行为。方法 :利用旋转薄膜 超声法制备环孢素纳米脂质体。采用大鼠在体回流法研究脂质体在大鼠小肠的吸收行为。结果 :当脂质体中药物浓度从 1g·L- 1逐渐增至 2 .4 g·L- 1时 ,累积吸收量从(0 .0 2 5±s 0 .0 2 4 )mg·cm- 2 增至 (0 .0 6 7± 0 .0 0 7)mg·cm- 2 ,但当浓度继续增至 7.5 g·L- 1时 ,累积吸收量缓慢增至 (0 .0 85± 0 .0 11)mg·cm- 2 ,呈现饱和现象。使用载体竞争剂和降低Na+浓度 ,对累积吸收量没有显著影响 (P >0 .0 5 ) ;应用能量抑制剂 (二硝基苯酚 )和P 糖蛋白抑制剂 (维拉帕米 )均使累积吸收量从 (0 .0 90± 0 .0 2 0 )mg·cm- 2 增至 (0 .15± 0 .0 3)mg·cm- 2 ,有显著促进作用 (P <0 .0 1)。结论 AIM: To investigate the absoption behavior of cyclosporin nanoliposome in the small intesteine of rats. METHODS: Cyclosporin nanoliposome was prepared by the rotary evaporation method, and further with sonication. In situ circulation method was utilized. RESULTS: As the concentration of cyclosporin increased from 1 g·L -1 to 2.4 g·L -1 , the accumulated absorption increased correspondingly from (0.025±0.024) mg·cm -2 to ( 0.067 ±0.007) mg·cm -2 . But when the concentration increased to 7.5 g·L -1 , the absorption amount increased steadily to (0.085±0.011) mg·cm -2 , which showed a saturated absorption. Neither carrier competitor nor decreasing the concentration of Na + had any influence on absorption ( P >0.05). Both the energy inhibitor(dinitrophenol) and P glycoprotein inhibitor(verapamil) increased the absorption, significantly from (0.090±0.020) mg·cm -2 to (0.15± 0.03 ) mg·cm -2 ( P <0.01). CONCLUSION: The absorption of cyclosporin nanoliposome in the small intestine of rats may be transported through phagcytosis of lymph system.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2003年第6期331-334,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 国家自然科学基金重点资助项目 ( 39930 2 0 0 )
关键词 环孢素 纳米脂质体 小肠 吸收 体肠回流法 淋巴系统 cyclosporin nanoliposomes small intestine absorption rats
  • 相关文献

参考文献7

  • 1张德昌 医学药理学.第1版[M].北京:北京医科大学和中国协和医科大学联合出版社,1989.51-52.
  • 2陈颖,平其能,郭健新,马珂.环孢素纳米脂质体的制备及在小鼠体内的组织分布[J].中国新药与临床杂志,2002,21(2):81-84. 被引量:11
  • 3BARTHE L,WOODLEY J ,HOUIN G. Gastrointestinal absorption of drugs:methods and studies [J]. Fundam Clin Pharmacol, 1999,13(2):154-168.
  • 4GUO JX, PING QN, CHEN Y. Pharmacokinetie behavior of cyclosporin A in rabbits by oral administration of lecition vesicle and sanimmun neural [J]. Int J Pharm, 2001,216( 1 ) ; 17-21.
  • 5CHIANG CM, WEINER N. Gastrointestinal uptake of liposomes I . In vitro and in situ studies [J]. Int J Pharm, 1987,37(1):75-85.
  • 6FAGERHOLM U, JOHANSSON M, LENNERNATS H. Comparison between permeability coefficients in rat and human jejunum[J ]. Pharm Res, 1996,13(9) : 1336-1342.
  • 7JANICE H, BARRY HH. Intestinal secretion of drugs. The role of P-glyeoprotein and related drug elilux systems in limiting oral drug absorption[ ] ]. Adv Drug Deliv Rev, 1997,25(2): 129-157.

二级参考文献1

共引文献10

同被引文献64

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部